---
title: "NYC Digital Health Raised $2.4B in H1 2025: The Sector Data Every Founder Should Know"
description: "NYC digital health raised $2.4B in H1 2025 (+10% YoY). Life sciences took 27% of NYC venture funding. Here's where the money went and who's writing checks."
date: 2026-04-18T00:00:00.000Z
tags: ["vc-explainers", "nyc-startups", "healthtech", "biotech", "market-analysis"]
source: https://venturecapitaltracker.com/nyc-digital-health-2-4b-h1-2025-sector-analysis
---

# NYC Digital Health Raised $2.4B in H1 2025: The Sector Data Every Founder Should Know

> NYC digital health raised $2.4B in H1 2025 (+10% YoY). Life sciences took 27% of NYC venture funding. Here's where the money went and who's writing checks.

NYC digital health grew 10% YoY in H1 2025 to **$2.4B** raised. Life sciences broadly captured **27% of all NYC venture funding**. Here's why the sector is a durable growth story.

### The data

- **$2.4B** — NYC digital health H1 2025 total (+10% YoY).
- **27%** — Life sciences/biotech share of NYC VC H1 2025.
- **#1** — NYC hospital system density in the U.S. (by population served).
- **1.08M jobs** — Healthcare + Social Assistance in NYC (Aug 2025, NYCEDC).

### Why NYC is a natural health hub

1. **Hospital density**: Mount Sinai, NYU Langone, NewYork-Presbyterian, Columbia, Weill Cornell, Memorial Sloan Kettering — world-class systems concentrated in a 10-mile radius.
2. **Research universities**: Columbia, Cornell, NYU, Rockefeller.
3. **Payer diversity**: Commercial insurers, Medicaid plans, Medicare Advantage plans — strong testing ground.
4. **Clinical talent pipeline**: Residents, fellows, researchers who stay in NYC.
5. **Investor cluster**: OrbiMed (NYC-HQ), Deerfield, Perceptive Advisors — some of the largest public/private health investors.

### Major NYC health investors in 2026

- **OrbiMed** — $20B+ AUM, NYC-HQ, life sciences breadth.
- **Deerfield Management** — NYC-HQ, public/private health.
- **Perceptive Advisors** — crossover biotech.
- **Flare Capital Partners** (Boston but NYC-active).
- **.406 Ventures** — digital health + cyber + cloud.
- **Casdin Capital** — life sciences hedge + VC.
- **General Catalyst** — health system partnerships model.
- **Thrive Capital** — Isomorphic Labs lead.

### Recent NYC health deals (2025–2026)

- **Avo** — $10M Series A in clinical AI.
- **Patlytics** — Series A for patent + clinical intelligence.
- **Faireez** — seed for compliance-adjacent care.
- **Hiveclass** — seed.
- **Junction** — Series A.

### NYC health themes that rank highly for VCs

1. **Workflow AI**: Documentation, coding, prior auth, scheduling.
2. **Revenue cycle**: AI-driven billing + collections.
3. **Specialty care platforms**: Oncology, behavioral health, cardiology.
4. **Value-based care enablement**: Risk-bearing software.
5. **AI drug discovery** (Isomorphic NYC presence, Insilico partnerships).

### Data on health-VC returns

Cambridge Associates' 2025 data shows that healthcare + IT + industrials together account for **85% of U.S. VC invested capital**, with healthcare deal sizes growing consistently. NYC's health VC share of this is disproportionately large for its population.

### Practical takeaway

- **Founders**: Health startups built near NYC hospitals have faster initial adoption. Co-locate early customers.
- **Investors**: NYC digital health is Series A+ heavy; seed rounds benefit from operator-angels (physicians, hospital execs).
- **LPs**: Allocate to sector-specialist NYC funds rather than generalist for health exposure.

### Sources

1. Crain's NY — Digital Health 2025: https://www.crainsnewyork.com/health-pulse/nycs-digital-health-sector-sees-slight-funding-uptick-2025/
2. NYCEDC State of the Economy 2025: https://edc.nyc/sites/default/files/2025-12/NYCEDC-2025-State-of-NYC-Economy_12-12-2025.pdf
3. Cambridge Associates H1 2025: https://www.cambridgeassociates.com/insight/us-pe-vc-benchmark-commentary-first-half-2025/

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.